Upjohn Inc Contracts & Agreements

66 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Viatris Inc. Employment Offer Letter for Chief Commercial Officer (Corinne Le Goff)
Employment Agreements
Upjohn Inc
Pharmaceuticals
2025
Amendment to the Viatris Inc. 2020 Stock Incentive Plan dated December 6, 2024
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
2025
Omnibus Amendment No. 3, effective as of December 24, 2024, by and among Viatris Inc., Biocon Biologics UK Limited, Biosimilar Collaborations Ireland Limited, Biosimilars Newco...
Upjohn Inc
Pharmaceuticals
2025
Separation Agreement and Release with Sanjeev Narula, dated December 15, 2023
Separation Agreements
Upjohn Inc
Pharmaceuticals
PA
2024
Separation Agreement and Release with Anthony Mauro, dated October 20, 2023
Separation Agreements
Upjohn Inc
Pharmaceuticals
PA
2024
Retirement and Operating Consulting Agreement and Release with Rajiv Malik, dated October 20, 2023
Consulting Agreements
Upjohn Inc
Pharmaceuticals
PA
2024
Offer Letter with Theodora (Doretta) Mistras, dated December 15, 2023
Upjohn Inc
Pharmaceuticals
2024
Description of Viatris Inc. Securities Registered Under Section 12 of the Exchange Act
Upjohn Inc
Pharmaceuticals
DE
2024
Omnibus Amendment No. 2, effective as of December 19, 2023, by and among Viatris Inc., Biocon Biologics UK Limited, Biosimilars Newco Limited, and Biocon Biologics Limited
Upjohn Inc
Pharmaceuticals
2024
Transaction Agreement, dated as of January 29, 2024, by and among Cooper Consumer Health SAS, Cooper Consumer Health IT S.r.l., Viatris Inc., Viatris Italia S.r.l. and Ipex AB
Upjohn Inc
Pharmaceuticals
NY
2024
Transition and Advisory Agreement and Release, dated May 19, 2023, by and between Viatris Inc. and Robert J. Coury
Transition Agreements
Upjohn Inc
Pharmaceuticals
NY
2023
Omnibus Amendment No. 1, effective as of May 17, 2023, by and among Viatris Inc., Biocon Biologics UK Limited, Biosimilar Collaborations Ireland Limited, Biosimilars Newco...
Upjohn Inc
Pharmaceuticals
2023
Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 3, 2023
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2023
Separation Agreement with Michael Goettler, dated February 24, 2023
Separation Agreements
Upjohn Inc
Pharmaceuticals
PA
2023
Offer Letter with Scott A. Smith, dated February 24, 2023
Upjohn Inc
Pharmaceuticals
2023
Amendment No. 1 to Transaction Agreement, dated as of November 28, 2022, by and between Biocon Biologics Limited and Viatris Inc
Upjohn Inc
Pharmaceuticals
NY
2022
Transaction Agreement, dated as of February 27, 2022, by and among Biocon Biologics Limited and Viatris Inc
Upjohn Inc
Pharmaceuticals
DE
2022
Term Loan Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders from time to time party thereto and Mizuho Bank,...
Loan Agreements
Upjohn Inc
Pharmaceuticals
NY
2021
Amended and Restated Revolving Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders and issuing banks from time...
Credit Agreements
Upjohn Inc
Pharmaceuticals
NY
2021
Form of Director Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for non-employee directors for awards granted on or after March 2, 2021
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Form of Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Amendment No. 1, dated as of November 5, 2020, to the Asset Purchase Agreement dated as of September 7, 2020, between Aspen Global Incorporated and Mylan Ireland Limited
Purchase Agreements
Upjohn Inc
Pharmaceuticals
2021
Value Creation Incentive Award Performance-Based Restricted Stock Unit Award Agreement for Robert J. Coury under the Viatris Inc. 2020 Stock Incentive Plan, effective as of...
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Letter Agreement entered into on February 6, 2020 by and between Pfizer Inc. and Sanjeev Narula
Upjohn Inc
Pharmaceuticals
2021
Letter Agreement entered into on June 25, 2019 by and between Pfizer Inc. and Sanjeev Narula
Upjohn Inc
Pharmaceuticals
2021
Letter Agreement entered into on June 26, 2019 by and between Pfizer Inc. and Michael Goettler
Upjohn Inc
Pharmaceuticals
2021
Letter Agreement entered into on July 29, 2019 by and between Pfizer Inc. and Michael Goettler
Upjohn Inc
Pharmaceuticals
2021
Severance Agreement entered into on December 3, 2020 by and between Viatris Inc. and Michael Goettler
Severance Agreements
Upjohn Inc
Pharmaceuticals
2021
Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Rajiv Malik
Retention Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Anthony Mauro
Retention Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Executive Employment Agreement, entered into on November 20, 2020, by and between Viatris Inc. and Robert J. Coury
Employment Agreements
Upjohn Inc
Pharmaceuticals
NY
2021
Form of Indemnification Agreement between Viatris Inc. and each of its directors and its executive officers
Indemnification Agreements
Upjohn Inc
Pharmaceuticals
DE
2021
Form of Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan for Michael Goettler and Sanjeev Narula
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Form of Retention Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Form of Make-Whole Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan
Bonus & Incentive Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Description of Viatris Inc. Securities Registered Under Section 12 of the Exchange Act
Upjohn Inc
Pharmaceuticals
DE
2021
First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and Citibank, N.A., London Branch, as...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture dated November 16, 2020, by and among Upjohn Finance B.V., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A.,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A., London Branch, as...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Third Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Fourth Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee,...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
2020
Form of Dealer Agreement among Viatris, Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the dealer thereto
Upjohn Inc
Pharmaceuticals
NY
2020
Amendment No. 4 to the Separation and Distribution Agreement, dated as of November 15, 2020, by and between Pfizer Inc. and Upjohn Inc
Separation Agreements
Upjohn Inc
Pharmaceuticals
2020
Trademark License Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc
Trademark Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Intellectual Property Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc
Upjohn Inc
Pharmaceuticals
DE
2020
Manufacturing and Supply Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Manufacturer) and Pfizer Inc. (as Customer)
Supply Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Manufacturing and Supply Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Manufacturer) and Upjohn Inc. (as Customer)
Supply Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Employee Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc
Upjohn Inc
Pharmaceuticals
UT
2020
Tax Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc
Upjohn Inc
Pharmaceuticals
DE
2020
Transition Services Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Service Provider) and Pfizer Inc. (as Service Recipient)
Transition Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Transition Services Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Service Provider) and Upjohn Inc. (as Service Recipient)
Transition Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Amendment No. 3 to the Separation and Distribution Agreement, dated as of September 18, 2020, by and between Pfizer Inc. and Upjohn Inc
Separation Agreements
Upjohn Inc
Pharmaceuticals
2020
Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc
Separation Agreements
Upjohn Inc
Pharmaceuticals
2020
Indenture, dated as of June 22, 2020, between Upjohn Inc., as issuer, and The Bank of New York Mellon, as trustee
Indenture Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Indenture, dated as of June 23, 2020, among Upjohn Finance B.V., as issuer, Upjohn Inc., as guarantor, and Citibank, N.A., London Branch, as trustee, transfer agent, paying agent...
Indenture Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Registration Rights Agreement, dated as of June 22, 2020, by and between Upjohn Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., Morgan...
Note Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Delayed Draw Term Loan Credit Agreement, dated as of June 16, 2020, among Upjohn, the guarantors from time to time party thereto, the lenders from time to time party thereto and...
Loan Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Revolving Credit Agreement, dated as of June 16, 2020, among Upjohn, the guarantors from time to time party thereto, the lenders and issuing banks from time to time party thereto...
Credit Agreements
Upjohn Inc
Pharmaceuticals
NY
2020
Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc
Separation Agreements
Upjohn Inc
Pharmaceuticals
UT
2020
Amendment No. 1, dated as of May 29, 2020, to the Business Combination Agreement, dated as of July 29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc.,...
Upjohn Inc
Pharmaceuticals
UT
2020
Amendment No. 1 to the Separation and Distribution Agreement, dated as of February 18, 2020, by and between Pfizer Inc. and Upjohn Inc
Separation Agreements
Upjohn Inc
Pharmaceuticals
2020